| 10/29 | GILEAD SCIENCES : Announces Fourth Quarter 2020 Dividend | AQ |
| 10/29 | GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results | AQ |
| 10/28 | GILEAD SCIENCES : View Third Quarter 2020 Earnings Slides | PU |
| 10/28 | GILEAD : 3Q Earnings Snapshot | AQ |
| 10/28 | GILEAD SCIENCES INC : Results of Operations and Financial Condition, Financial S.. | AQ |
| 10/28 | GILEAD SCIENCES : Announces Fourth Quarter 2020 Dividend | BU |
| 10/28 | GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results | BU |
| 10/26 | GILEAD SCIENCES : Completes Acquisition of Immunomedics, Inc. | AQ |
| 10/26 | LIGAND PHARMACEUTICALS INCORPORATED : Captisol Technology Plays Key Role in the .. | AQ |
| 10/23 | GILEAD SCIENCES INC : Completion of Acquisition or Disposition of Assets, Other .. | AQ |
| 10/23 | Intel, American Express fall; Mattel, Boston Beer rise | AQ |
| 10/23 | GILEAD SCIENCES : Anthony Welters Joins Gilead Sciences Board of Directors | AQ |
| 10/23 | GILEAD SCIENCES : U.S. Food and Drug Administration Approves Gilead's Antiviral .. | AQ |
| 10/23 | Noveome Biotherapeutics, Inc. Announces New Appointments to its Board of Dire.. | AQ |
| 10/23 | GILEAD SCIENCES : Completes Acquisition of Immunomedics, Inc. | BU |
| 10/22 | GILEAD SCIENCES : FDA approves remdesivir to treat hospitalized COVID-19 patient.. | AQ |
| 10/22 | FDA APPROVES FIRST COVID-19 DRUG : antiviral remdesivir | AQ |
| 10/22 | FDA APPROVES FIRST COVID-19 DRUG : antiviral remdesivir | AQ |
| 10/22 | GILEAD SCIENCES : U.S. Food and Drug Administration Approves Gilead's Antiviral .. | BU |
| 10/22 | GILEAD SCIENCES INC : Change in Directors or Principal Officers, Financial State.. | AQ |
| 10/22 | GILEAD SCIENCES : Anthony Welters Joins Gilead Sciences' Board of Directors | BU |
| 10/22 | GILEAD SCIENCES : Announces New Data on Biktarvy for the Treatment of HIV in Bla.. | AQ |
| 10/21 | GILEAD SCIENCES : Announces New Data on Biktarvy® for the Treatment of HIV in Bl.. | BU |
| 10/20 | GILEAD SCIENCES : Presents New Data from Antiviral Development Programs at IDWee.. | AQ |
| 10/19 | GILEAD SCIENCES : European CHMP Adopts Positive Opinion for Kite's KTE-X19 for t.. | AQ |
| 10/19 | GILEAD SCIENCES : Presents New Data from Antiviral Development Programs at IDWee.. | BU |
| 10/16 | GILEAD SCIENCES : Statement on the Solidarity Trial | PU |
| 10/16 | GILEAD SCIENCES : European CHMP Adopts Positive Opinion for Kite's KTE-X19 for t.. | BU |
| 10/15 | GILEAD SCIENCES : nbsp;Statement on the Solidarity Trial | PU |
| 10/15 | GILEAD SCIENCES : to Release Third Quarter 2020 Financial Results on Wednesday, .. | AQ |
| 10/15 | GILEAD SCIENCES : Announces Expiration of Hart-Scott-Rodino Waiting Period for I.. | AQ |
| 10/14 | GILEAD SCIENCES : to Release Third Quarter 2020 Financial Results on Wednesday, .. | BU |
| 10/14 | GILEAD SCIENCES : Announces Expiration of Hart-Scott-Rodino Waiting Period for I.. | BU |
| 10/13 | GILEAD SCIENCES INC. : - Phase 2b/3 Trial Shows Efficacy of Filgotinib for the I.. | AQ |
| 10/09 | NXP, Matson rise; Advanced Micro Devices, Mallinckrodt fall | AQ |
| 10/09 | GILEAD SCIENCES : Signs Joint Procurement Agreement with the European Commission.. | AQ |
| 10/09 | GILEAD SCIENCES : Final Results of National Institute of Allergy and Infectious .. | AQ |
| 10/08 | GILEAD SCIENCES : to sell Europe 500,000 doses of remdesivir | AQ |
| 10/08 | GILEAD SCIENCES : Final Results of National Institute of Allergy and Infectious .. | BU |
| 10/08 | GILEAD SCIENCES : Signs Joint Procurement Agreement With the European Commission.. | BU |
| 10/06 | GILEAD SCIENCES : Presents Biktarvy Findings from Switch Studies and Analysis of.. | AQ |
| 10/05 | REGENERON PHARMACEUTICALS : What we know, and what we don't, about Trump's diagn.. | AQ |
| 10/05 | GILEAD SCIENCES : Presents Biktarvy® Findings From Switch Studies & Analysis of .. | BU |
| 10/05 | GILEAD SCIENCES : Presents Biktarvy® Findings From Switch Studies & Analysis of .. | BU |
| 10/05 | GILEAD SCIENCES : Presents Biktarvy® Findings From Switch Studies & Analysis of .. | BU |
| 10/03 | GILEAD SCIENCES : Trump treated with remdesivir at Walter Reed, doctor says | AQ |
| 10/02 | GILEAD SCIENCES : Update on Supply and Distribution of Veklury in the United Sta.. | AQ |
| 10/01 | GILEAD SCIENCES : resumes control of remdesivir distribution | AQ |
| 10/01 | GILEAD SCIENCES : Update on Supply and Distribution of Veklury® (remdesivir) in .. | BU |
| 10/01 | GILEAD SCIENCES : Presents Data from HIV Research and Development Programs at HI.. | AQ |
| 09/30 | GILEAD SCIENCES : Presents Data From HIV Research and Development Programs at HI.. | BU |
| 09/30 | GILEAD SCIENCES INC : Entry into a Material Definitive Agreement, Creation of a .. | AQ |
| 09/29 | GILEAD SCIENCES INC : Entry into a Material Definitive Agreement, Financial Stat.. | AQ |
| 09/28 | Gilead Sciences, Inc. - Jyseleca Approved in Japan for Rheumatoid Arthritis | AQ |
| 09/28 | GILEAD SCIENCES : European Commission Grants Marketing Authorization for Jyselec.. | AQ |
| 09/25 | GILEAD SCIENCES : Jyseleca® (Filgotinib) Approved in Japan for Rheumatoid Arthri.. | BU |
| 09/24 | GILEAD SCIENCES : Prices $7.25 Billion of Senior Unsecured Notes | AQ |
| 09/23 | GILEAD SCIENCES : Prices $7.25 Billion of Senior Unsecured Notes | BU |
| 09/17 | GILEAD SCIENCES : to acquire Immunomedics for $21 billion | AQ |
| 09/16 | GILEAD SCIENCES : Magrolimab an Investigational Anti-CD47 Monoclonal Antibody, R.. | AQ |
| 09/15 | GILEAD SCIENCES : Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, .. | BU |
| 09/14 | IMMUNOMEDICS : Wall Street posts solid gains after surge in corporate deals | AQ |
| 09/14 | GILEAD SCIENCES : to Acquire Immunomedics | AQ |
| 09/14 | IMMUNOMEDICS : Gilead Sciences buying Immunomedics in $21 billion deal | AQ |
| 09/14 | GILEAD SCIENCES INC : Entry into a Material Definitive Agreement, Other Events, .. | AQ |
| 09/14 | IMMUNOMEDICS : Gilead Sciences buying Immunomedics in $21 billion deal | AQ |
| 09/07 | GILEAD SCIENCES : Company - Kite Submits Supplemental Biologics License Applicat.. | AQ |
| 09/04 | GILEAD SCIENCES : Kite and HiFiBiO Therapeutics Partner to Discover Novel Target.. | AQ |
| 09/04 | GILEAD SCIENCES : Kite Submits Supplemental Biologics License Application to U.S.. | BU |
| 09/03 | GILEAD SCIENCES : Kite and HiFiBiO Therapeutics Partner to Discover Novel Target.. | BU |
| 09/01 | GILEAD SCIENCES : FDA expands emergency use authorisation for remdesivir to trea.. | AQ |
| 08/31 | GILEAD SCIENCES : Investigational Antiviral Veklury Receives U.S. Food and Drug .. | AQ |
| 08/28 | GILEAD SCIENCES : Investigational Antiviral Veklury® (Remdesivir) Receives U.S. .. | BU |
| 08/26 | GILEAD SCIENCES : Announces Presentation of More Than 40 Abstracts from Extensiv.. | AQ |
| 08/25 | GILEAD SCIENCES : Announces Presentation of More Than 40 Abstracts From Extensiv.. | BU |
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
